Authors: De Mulder, PHM Theodore, C Sella, A Koriakine, O Sternberg, CN Collette, L de Balincourt, C

Citation: Phm. De Mulder et al., Phase II EORTC trial with 5-fluorouracil, cisplatin and interferon-alpha as second-line treatment of advanced transitional cell cancer of the urothelial tract, ANN ONCOL, 11(11), 2000, pp. 1391-1394

Authors: van Herpen, CML De Mulder, PHM

Citation: Cml. Van Herpen et Phm. De Mulder, Locoregional immunotherapy in cancer patients: Review of clinical studies, ANN ONCOL, 11(10), 2000, pp. 1229-1239

Authors: Haicheur, N Escudier, B Dorval, T Negrier, S De Mulder, PHM Dupuy, JM Novick, D Guillot, T Wolf, S Pouillart, P Fridman, WH Tartour, E

Citation: N. Haicheur et al., Cytokines and soluble cytokine receptor induction after IL-12 administration in cancer patients, CLIN EXP IM, 119(1), 2000, pp. 28-37

Authors: van Herpen, CML Jansen, RLH Kruit, WHJ Hoekman, K Groenewegen, G Osanto, S De Mulder, PHM

Citation: Cml. Van Herpen et al., Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluorouracilfor progressive metastatic renal cell carcinoma: a multicenter phase II study, BR J CANC, 82(4), 2000, pp. 772-776